Beyond therapeutics, monoclonal antibodies shown to be effective in the clinic can help to facilitate laboratory research. Researchers use mAbs, also known as biosimilars, as tools to research novel therapies and uncover effective off-target applications. With known and approved data on toxicity and efficacy, researchers use these biologics as benchmarks in their studies, allowing them to accelerate their findings from bench to clinic.
ProSci offers more than 800 research-grade biosimilar antibodies in the following research areas: cancer, pain, blood-related diseases, bacterial infection, neurodegenerative, asthma, psoriasis and other dermatitis, rheumatoid arthritis and osteoporosis, inflammatory diseases, Crohn’s disease, virus infection, and diabetes and other autoimmune diseases.
Phone: 02 9698 2022
Antibodies Inc recombinant antibodies
Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.
Bioss Multiplex Fluorescent IHC Staining Kit
The Bioss Multiplex Fluorescent (5 Colors) IHC Staining Kit enables the simultaneous detection of...
AdipoGen immune checkpoint reagents for immuno-oncology research
AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...
